Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2024 08:00 ET | Source: ViaDerma, Inc.

ViaDerma Announces Significant 2024 Achievements and International Expansion

LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
December 05, 2024 08:30 ET | Source: iMD Companies, Inc.

iMD Companies and Its Subsidiary, Riize Health, Announce New Verticals With White Label and Licensing

RANCHO CORDOVA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- IMD Companies, Inc. (OTC:ICBU) and its subsidiary, Riize LLC (Riize Health), is pleased to announce the launch of our white label and...
December 04, 2024 17:11 ET | Source: Licensing International Foundation

Licensing International Honors Joseph Kaminkow, Maca Rotter, and Stu Seltzer at 2024 Hall of Fame Event

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Licensing International, the leading trade association for the $356-billion global brand licensing industry, and the Licensing International Foundation,...
December 04, 2024 07:30 ET | Source: Theratechnologies

Theratechnologies annonce la conclusion d’un contrat de licence exclusive avec Ionis visant la commercialisation de l’olezarsen et du donidalorsen au Canada

L’ajout de médicaments expérimentaux ciblant l’ARN renforce le portefeuille fondamental de Theratechnologies dans le domaine du VIH Des demandes visant ces médicaments devraient être soumises à...
December 04, 2024 07:30 ET | Source: Theratechnologies

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

Addition of investigational RNA-targeted medicines build upon Theratechnologies’ foundational HIV portfolio Submissions to Health Canada planned for 2025 MONTREAL, Dec. 04, 2024 (GLOBE NEWSWIRE)...
November 20, 2024 11:00 ET | Source: SBX Group

The Smurf Experience - A 13,000-Square-Foot Family Attraction - Sets its U.S. Debut for Early 2025

Media kit link to high-res logos and images of the exhibition MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Following a record of success in Europe, The Smurf Experience will make its U.S. debut in...
November 15, 2024 04:30 ET | Source: Numab Therapeutics AG; Kaken Pharmaceutical Co., Ltd.

Numab Therapeutics and Kaken Pharmaceutical Enter Collaboration and Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease

Numab to receive R&D funding for the preclinical development of ND081 Kaken Pharmaceutical receives an option to in-license ND081 in certain Asian territories in exchange for funding global...
November 07, 2024 16:12 ET | Source: Adeia Inc.

Adeia Announces Third Quarter 2024 Financial Results

Signed 7 deals across multiple verticals in the third quarterBoard increased share repurchase authorization up to $200 millionFiled patent infringement litigation against DisneySigned a new...
September 10, 2024 08:00 ET | Source: ViaDerma, Inc.

ViaDerma Completes First Shipment of 500,000 Units to Nigeria

LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
July 16, 2024 08:00 ET | Source: PLBY Group, Inc.

Playboy Enters Long-Term License Agreement for Condoms

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...